Nabsys

Biotechnology, Genetics, Health Care, Medical
Founded in 1/1/04
Providence, Rhode Island, United States
http://www.nabsys.com
For Profit

About Nabsys

Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic high-definition mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to receive a “1000 Genome” award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis. It was founded in 2004 and headquartered in Providence, Rhode Island.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 14 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 143299975 USD
  • Last Funding: 13000000 USD (Corporate Round)
  • Funding Status:

Technology Stack

Nabsys actively uses 14 products in their tech stack.

Market Presence

Industries: Biotechnology, Genetics, Health Care, Medical

Headquarters: Providence, Rhode Island, United States

Leadership

Employees

  • John Oliver - Chief Scientific Officer (LinkedIn)
  • Justin Bingham - Chief Commercial Officer (CCO) (LinkedIn)
  • Kevin Degeeter - Chief Financial Officer (LinkedIn)